Product
SIM0417
4 clinical trials
5 indications
Indication
Healthy Male VolunteersIndication
COVID-19Indication
Renal ImpairmentIndication
Liver ImpairmentIndication
Healthy Control ParticipantsClinical trial
A Phase I Study to Investigate The Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male ParticipantsStatus: Completed, Estimated PCD: 2022-08-07
Clinical trial
A Multicenter, Randomized, Double-blind, Phase Ⅱ/Ⅲ Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19Status: Completed, Estimated PCD: 2023-01-23
Clinical trial
A Multicenter, Non-randomized, Open-label, Parallel Controlled Phase I Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of SIM0417/Ritonavir After a Single Dose in Subjects With Renal or Hepatic ImpairmentStatus: Not yet recruiting, Estimated PCD: 2023-12-01
Clinical trial
An Open Labe Study to Evaluate the Drug-Drug Interaction of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy Adult Chinese ParticipantsStatus: Completed, Estimated PCD: 2023-01-26